Histone deacetylase inhibitors rescue the impaired memory in terrestrial snails

被引:0
|
作者
Alena B. Zuzina
Alia Kh. Vinarskaya
Pavel M. Balaban
机构
[1] Russian Academy of Sciences,Institute of Higher Nervous Activity and Neurophysiology
来源
关键词
Sodium butyrate; Trichostatin A; Memory reinstatement; Gastropods; Epigenetics;
D O I
暂无
中图分类号
学科分类号
摘要
It is becoming increasingly clear that the long-term plasticity can be regulated via histone modifications. Many studies demonstrated the role of histone acetylation in acquisition, maintenance, and extinction of long-term memory. Nonetheless, the role of histone acetylation in memory reinstatement following its disruption by antimnemonic treatments was not studied in details. In terrestrial snails, we examined effects of the histone deacetylases inhibitors (HDACi) sodium butyrate (NaB) and trichostatin A (TSA) on reinstatement of the context fear memory impaired by antimnemonic agents such as protein synthesis blocker anisomycin (ANI) + reminding or a specific inhibitor of protein-kinase Mζ, zeta inhibitory peptide (ZIP). It was observed that both NaB and TSA applications restored the ANI-impaired context memory regardless of memory reactivation, while a combination of NaB or TSA plus memory reactivation (or additional training) was necessary for the effective reinstatement of the ZIP-impaired memory. Additionally, NaB injections significantly facilitated development of long-term memory in animals with weak memory, while no effect was observed in animals with strong memory. The data obtained confirmed the assumption that histone acetylation is a critical regulatory component of memory development and reinstatement.
引用
收藏
页码:639 / 649
页数:10
相关论文
共 50 条
  • [31] Histone deacetylase inhibitors in cancer therapy
    Lee, Min-Jung
    Kim, Yeong Sang
    Kummar, Shivaani
    Giaccone, Giuseppe
    Trepel, Jane B.
    CURRENT OPINION IN ONCOLOGY, 2008, 20 (06) : 639 - 649
  • [32] Histone deacetylase inhibitors that target tubulin
    Schemies, Joerg
    Sippl, Wolfgang
    Jung, Manfred
    CANCER LETTERS, 2009, 280 (02) : 222 - 232
  • [33] Design of novel histone deacetylase inhibitors
    Siliphaivanh, Phieng
    Harrington, Paul
    Wittera, David J.
    Ottea, Karin
    Tempest, Paul
    Kattar, Sam
    Kral, Astrid M.
    Fleming, Judith C.
    Deshmukh, Sujal V.
    Harsch, Andreas
    Secrist, Paul J.
    Miller, Thomas A.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2007, 17 (16) : 4619 - 4624
  • [34] Histone deacetylase inhibitors and cell death
    Zhang, Jing
    Zhong, Qing
    CELLULAR AND MOLECULAR LIFE SCIENCES, 2014, 71 (20) : 3885 - 3901
  • [35] Discovery and development of histone deacetylase inhibitors
    Yoshida, M
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2005, 229 : U162 - U162
  • [36] HDACiDB: a database for histone deacetylase inhibitors
    Murugan, Kasi
    Sangeetha, Shanmugasamy
    Ranjitha, Shanmugasamy
    Vimala, Antony
    Al-Sohaibani, Saleh
    Rameshkumar, Gopal
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2015, 9 : 2257 - 2264
  • [37] Function of Histone Deacetylase Inhibitors in Inflammation
    Grabiec, Aleksander M.
    Tak, Paul P.
    Reedquist, Kris A.
    CRITICAL REVIEWS IN IMMUNOLOGY, 2011, 31 (03) : 233 - 263
  • [38] Histone deacetylase inhibitors in clinical development
    Rosato, RR
    Grant, S
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2004, 13 (01) : 21 - 38
  • [39] Histone deacetylase inhibitors in multiple myeloma
    Deleu, Sarah
    Menu, Eline
    Van Valckenborgh, Els
    Van Camp, Ben
    Fraczek, Joanna
    Broek, Isabelle Vande
    Rogiers, Vera
    Vanderkerken, Karin
    HEMATOLOGY REPORTS, 2009, 1 (01) : 46 - 55
  • [40] Mechanisms of Resistance to Histone Deacetylase Inhibitors
    Lee, Ju-Hee
    Choy, Megan L.
    Marks, Paul A.
    HISTONE DEACETYLASE INHIBITORS AS CANCER THERAPEUTICS, 2012, 116 : 39 - 86